CELGENE CORP Indenture Agreements

15 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
First Supplemental Indenture, dated May 1, 2019, to Indenture, dated February 20, 2018 by and between Celgene Corporation, as Issuer, and The Bank of New York Mellon Trust...
Indenture Agreements
CELGENE CORP
Pharmaceuticals
NY
2019
First Supplemental Indenture, dated May 1, 2019, to Indenture, dated November 9, 2017 by and between Celgene Corporation, as Issuer, and The Bank of New York Mellon Trust Company,...
Indenture Agreements
CELGENE CORP
Pharmaceuticals
NY
2019
First Supplemental Indenture, dated May 1, 2019, to Indenture, dated August 10, 2017 by and between Celgene Corporation, as Issuer, and The Bank of New York Mellon Trust Company,...
Indenture Agreements
CELGENE CORP
Pharmaceuticals
NY
2019
First Supplemental Indenture, dated May 1, 2019, to Indenture, dated August 12, 2015 by and between Celgene Corporation, as Issuer, and The Bank of New York Mellon Trust Company,...
Indenture Agreements
CELGENE CORP
Pharmaceuticals
NY
2019
First Supplemental Indenture, dated May 1, 2019, to Indenture, dated May 15, 2014 by and between Celgene Corporation, as Issuer, and The Bank of New York Mellon Trust Company,...
Indenture Agreements
CELGENE CORP
Pharmaceuticals
NY
2019
First Supplemental Indenture, dated May 1, 2019, to Indenture, dated August 6, 2013 by and between Celgene Corporation, as Issuer, and The Bank of New York Mellon Trust Company,...
Indenture Agreements
CELGENE CORP
Pharmaceuticals
NY
2019
First Supplemental Indenture, dated May 1, 2019, to Indenture, dated August 9, 2012 by and between Celgene Corporation, as Issuer, and The Bank of New York Mellon Trust Company,...
Indenture Agreements
CELGENE CORP
Pharmaceuticals
NY
2019
First Supplemental Indenture, dated May 1, 2019, to Indenture, dated October 7, 2010 by and between Celgene Corporation, as Issuer, and The Bank of New York Mellon Trust Company,...
Indenture Agreements
CELGENE CORP
Pharmaceuticals
NY
2019
Indenture, dated as of February 20, 2018, relating to the 2.875% Senior Notes due 2021, the 3.250% Senior Notes due 2023, the 3.900% Senior Notes due 2028 and the 4.550% Senior...
Indenture Agreements
CELGENE CORP
Pharmaceuticals
NY
2018
Indenture, dated as of November 9, 2017, relating to the 2.750% Senior Notes due 2023, the 3.450% Senior Notes due 2027 and the 4.350% Senior Notes due 2047 between the Company...
Indenture Agreements
CELGENE CORP
Pharmaceuticals
NY
2017
CELGENE CORPORATION, as Issuer, and TheBank of New York Mellon Trust Company, N.A., as Trustee INDENTURE Dated as of August 12, 2015
Indenture Agreements
CELGENE CORP
Pharmaceuticals
NY
2015
CELGENECORPORATION, as Issuer, and THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A., as Trustee INDENTURE Dated as of May 15, 2014
Indenture Agreements
CELGENE CORP
Pharmaceuticals
NY
2014
CELGENE CORPORATION, as Issuer, and THE BANK OFNEW YORK MELLON TRUST COMPANY, N.A., as Trustee INDENTURE Dated as of August 6, 2013 CROSS-REFERENCE TABLE
Indenture Agreements
CELGENE CORP
Pharmaceuticals
NY
2013
CELGENE CORPORATION, as Issuer, and THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A., as Trustee INDENTURE Dated as of August 9, 2012 CROSS-REFERENCE TABLE
Indenture Agreements
CELGENE CORP
Pharmaceuticals
NY
2012
CELGENE CORPORATION, as Issuer, and THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A., as Trustee INDENTURE Datedas of October 7, 2010
Indenture Agreements
CELGENE CORP
Pharmaceuticals
NY
2010